SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in SingaporeArticle Published on 2022-02-182022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibodies antibody Antibody Response BNT162b2 booster vaccination COVID-19 cut-off Day declined decrease dose Elecsy evaluated Evidence had no half-live Kinetics median mRNA neutralizing antibody nucleocapsid of BNT162b2 participant peaked Quantitative regression estimate reported Roche SARS-CoV-2 SARS-CoV-2 nucleocapsid second dose Singapore spike tested Total undetectable vaccination were assessed [DOI] 10.3390/vaccines10020331 PMC 바로가기 [Article Type] Article
Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections—an Open Observational Study in Lower Saxony, Germany선택된 코호트의 결합된 예상 혈청전환 및 PCR 데이터는 무증상 SARS-CoV-2 감염의 높은 비율을 나타냅니다 - 독일 Lower Saxony에서 열린 관찰 연구Observational Study Published on 2022-02-162022-09-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, [키워드] acute infection acute SARS-CoV-2 infection addition antibody screening antibody screening tests Antibody testing Antigen Asymptomatic characteristic Charlson Comorbidity Index Combined Comorbidities Comorbidity conducted Contact contribute contributed COVID-19 COVID-19 symptoms detectable Elecsy Elecsys Germany group IgG immunization individuals Infection Intervention lockdown low grade Lower Measures NAb titer NAb titers NAbs Neutralizing Neutralizing antibodies observational study offered open pandemic pandemic virus participated PCR PCR testing PCR tests PCR-confirmed performed positive PCR test Prevalence Prospective Rapid test Rate reduce repeated reported risk Roche SARS-CoV-2 SARS-CoV-2 antibody screening SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 pandemic SARS-CoV-2 PCR test Seroconversion seroconverted serum antibodies serum antibody significantly significantly lower specific antibody Spread Subclinical subclinical cases subject subjects supported Symptom symptomatic and asymptomatic symptoms of COVID-19 symptoms prior Test screening the SARS-CoV-2 Virus neutralization was performed working groups [DOI] 10.1128/spectrum.01512-21 PMC 바로가기 [Article Type] Observational Study
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individualsSARS-CoV-2에 대한 타액 IgG는 혈청 전환을 나타내며 mRNA 백신 접종 면역 저하된 개인의 혈청 중화와 상관 관계가 있습니다Article Published on 2022-02-112022-09-12 Journal: Med (New York, N.Y.) [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] acute respiratory syndrome ALF Allogeneic Analysis Anti-SARS-CoV-2 S antibody Antigen AUC Cancer CAR-T caused center CLL CLL patient comparable coronavirus correlated Council COVID-19 disease dose Elecsy entire cohort foundation group healthy control HIV Human immunodeficiency virus IgG IgG response IgG titer immunocompromised individual immunodeficiency Immunoglobulin immunosuppressants indicate individual Infection Innovation Knut leukemia Medical Research Council mRNA BNT162b2 mRNA BNT162b2 vaccine multiplex neutralizing capacity parameter participated Patient PID Positive predictive value PPV predictive power Primary Immunodeficiency primary site Prospective clinical trial reactivity receiver operating characteristic receptor Region response responses revaccination Saliva salivary SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 spike antigen Seroconversion serum Serum Neutralization solid organ transplantation SOT spike IgG Stem cell transplantation Stockholm County susceptible Swedish T cell therapy transplantation vaccination vaccine response Vaccine-induced immunity were measured [DOI] 10.1016/j.medj.2022.01.001 PMC 바로가기 [Article Type] Article
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies혈액암 환자에서 mRNA-1273 SARS-CoV-2 백신의 세포 및 체액 면역원성Article Published on 2022-02-082022-09-12 Journal: Blood advances [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Active disease acute respiratory syndrome age anti-CD20 therapy Anti-SARS-CoV-2 S assays B-cell cellular cellular response coronavirus diagnosed disease Elecsy evaluate GVHD hematologic Hematologic malignancy humoral Humoral immunity humoral immunogenicity Humoral response immunoassay Immunosuppressive agents Immunosuppressive treatment implication interferon-γ LIAISON lymphopenia management Messenger RNA mRNA mRNA-1273 mRNA-1273 vaccine observation Patient patients patients treated preserved recent SARS-CoV-2 SARS-CoV-2 vaccine second dose shown T-cell T-cell Response the SARS-CoV-2 Treatment Vaccine were measured [DOI] 10.1182/bloodadvances.2021006101 PMC 바로가기 [Article Type] Article
Comparison of six antibody assays and two combination assays for COVID-19COVID-19에 대한 6 개의 항체 분석 및 2 개의 조합 분석의 비교Comparative Study Published on 2022-02-032022-09-01 Journal: Virology Journal [Category] COVID19(2023년), Fulltext, MERS, SARS, 진단, [키워드] antibody assay Antibody testing Combination concordance rate COVID-19 COVID-19 diagnosis COVID-19 group COVID-19 infection COVID-19 patient early stage Elecsy Elecsys epidemiological epidemiological surveillance evaluated Evidence evidence of except for Flash iFlash IgG IgM individual late stage negative control performed PerkinElmer Result SARS-CoV-2 SARS-COV-2 infection sensitive assay sensitivity serology seropositive serum sample serum samples specificity Surveillance symptom onset [DOI] 10.1186/s12985-022-01752-y PMC 바로가기 [Article Type] Comparative Study
Comparison of Anti-SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA VaccineBNT162b2 mRNA 백신 전과 후 의료 종사자의 Anti-SARS-CoV-2 S1 수용체 결합 도메인 항체 면역 측정법의 비교Article Published on 2022-02-032022-09-11 Journal: American journal of clinical pathology [Category] COVID19(2023년), SARS, 치료기술, 치료법, [키워드] 2019-nCoV anti-RBD antibody antibody concentration antibody production assays biomedical engineering blood sample Blood samples BNT162b2 BNT162b2 mRNA BNT162b2 vaccine booster dose Care collected COVID-19 DiaSorin dose Elecsy Elecsys Engineering evaluated Health Health care IgG immunoassay immunoassays Immunoglobulin Immunoglobulin G induce interquartile range LIAISON median medians New nucleocapsid protein Nucleocapsid proteins Pfizer Pfizer-BioNTech professional RBD Receptor-binding domain Roche Roche Diagnostics S-RBD SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection Siemens Healthineers Snibe Diagnostics spike glycoprotein statistically significant tested the median the receptor-binding domain the vaccine Type of antibody U/mL vaccination Vaccine were measured worker [DOI] 10.1093/ajcp/aqab107 PMC 바로가기 [Article Type] Article
Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers무증상 건강한 지원자의 혈청역학 연구에서 SARS-CoV-2 IgM 및 IgG 항체 역가의 해석Article Published on 2022-02-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abbott acute respiratory syndrome anti-SARS-CoV-2 Antibody test Antibody titer Architect Architect SARS-CoV-2 IgG Asymptomatic asymptomatic individual Asymptomatic volunteers collected combined use coronavirus COVID-19 cutoff value Elecsy Elecsys anti-SARS-CoV-2 Ig elevated Follow-up healthy subjects healthy volunteer iFlash-SARS-CoV-2 IgM and IgG. IgG IgG antibody titer IgG titer IgG titers IgM IgM and IgG Interpretation investigated participant Participants performed positive Proteins RBD RBD protein RBD proteins reactivity Receptor binding domain recruited reflected Roche SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgM Sensitivity and specificity Seroepidemiological study serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) survey Symptomatic patients titer Tokyo total Ig university [DOI] 10.1016/j.jiac.2021.11.020 PMC 바로가기 [Article Type] Article
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2SARS-COV-2에 대한 검출 가능한 항체를 측정 할 때 혈청 학점 테스트의 성능 평가Research Article Published on 2022-01-312022-09-10 Journal: PLoS ONE [Category] 진단, 치료기술, [키워드] 95% CI antibody Antibody test Antibody titers assays Assessing association Cohen’s kappa Concordance conducted COVID-19 demonstrated detectable Elecsy Elecsys IgM/IgG individuals investigated Logistic regression Metrics platform point-of-care positive Public health response Public health responses Rapid Rapid test Roche Roche Elecsys Anti-SARS-CoV-2 assay SARS-CoV-2 SARS-CoV-2 seroprevalence serological Serological testing seronegative seropositive Seropositivity specimen Test utility Vaccine was used [DOI] 10.1371/journal.pone.0262897 PMC 바로가기 [Article Type] Research Article
Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian RegionArticle Published on 2022-01-272022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% CI Antigen Asian automated central laboratory testing complement consecutive sample Control COVID-19 COVID-19 case cut-off cycle threshold disease onset Elecsy evaluated immunoassay Laboratory limit linear Patient performed positive positive COVID-19 Precision reactive reactivity Region Roche RT-PCR RT-PCR Ct RT-PCR tests SARS-CoV-2 SARS-CoV-2 antigen scaled sensitivity Sensitivity and specificity specificity the SARS-CoV-2 validation [DOI] 10.3390/vaccines10020198 PMC 바로가기 [Article Type] Article
Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare WorkersCommunication Published on 2022-01-262022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Abbott Abbott SARS-CoV-2 IgG II Quant assay acute respiratory syndrome adverse event adverse events antibody Antibody assays Antibody Response AstraZeneca-Oxford blood specimen BNT162b2 ChAdOx1 collected coronavirus Coronavirus disease 2019 correlated COVID-19 COVID-19 vaccination COVID-19 vaccine Elecsy Elecsys Anti-SARS-CoV-2 S assay group healthcare healthcare worker Inc. investigated janssen JNJ-78436735 Moderna mRNA-1273 neutralizing antibody Pfizer-BioNTech Pfizer/BioNTech positive rate questionnaire reached response Roche Diagnostics SARS-CoV-2 SARS-CoV-2 IgG significantly significantly increased South Korea specimen subject the vaccine vaccination Vaccine was tested was used worker [DOI] 10.3390/vaccines10020193 PMC 바로가기 [Article Type] Communication